CN108076643B - 用于治疗例如细菌性阴道病的鼠李糖乳杆菌细菌 - Google Patents

用于治疗例如细菌性阴道病的鼠李糖乳杆菌细菌 Download PDF

Info

Publication number
CN108076643B
CN108076643B CN201680036708.XA CN201680036708A CN108076643B CN 108076643 B CN108076643 B CN 108076643B CN 201680036708 A CN201680036708 A CN 201680036708A CN 108076643 B CN108076643 B CN 108076643B
Authority
CN
China
Prior art keywords
dietary
pharmaceutical composition
composition
lactobacillus
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201680036708.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN108076643A (zh
Inventor
M·E·彻诺夸德罗斯
B·卡西诺斯拉莫
A·席尔瓦安古洛
D·拉蒙维达尔
S·赫诺韦斯马丁内斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Firelink Pharmaceuticals
Original Assignee
Firelink Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Firelink Pharmaceuticals filed Critical Firelink Pharmaceuticals
Priority to CN202110848314.7A priority Critical patent/CN113564075A/zh
Publication of CN108076643A publication Critical patent/CN108076643A/zh
Application granted granted Critical
Publication of CN108076643B publication Critical patent/CN108076643B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
CN201680036708.XA 2015-06-29 2016-06-29 用于治疗例如细菌性阴道病的鼠李糖乳杆菌细菌 Active CN108076643B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110848314.7A CN113564075A (zh) 2015-06-29 2016-06-29 用于治疗例如细菌性阴道病的鼠李糖乳杆菌细菌

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPEP15174222.8 2015-06-29
EP15174222 2015-06-29
PCT/EP2016/065074 WO2017001440A1 (en) 2015-06-29 2016-06-29 Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202110848314.7A Division CN113564075A (zh) 2015-06-29 2016-06-29 用于治疗例如细菌性阴道病的鼠李糖乳杆菌细菌

Publications (2)

Publication Number Publication Date
CN108076643A CN108076643A (zh) 2018-05-25
CN108076643B true CN108076643B (zh) 2021-09-21

Family

ID=53496506

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201680036708.XA Active CN108076643B (zh) 2015-06-29 2016-06-29 用于治疗例如细菌性阴道病的鼠李糖乳杆菌细菌
CN202110848314.7A Pending CN113564075A (zh) 2015-06-29 2016-06-29 用于治疗例如细菌性阴道病的鼠李糖乳杆菌细菌

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202110848314.7A Pending CN113564075A (zh) 2015-06-29 2016-06-29 用于治疗例如细菌性阴道病的鼠李糖乳杆菌细菌

Country Status (9)

Country Link
US (2) US10588926B2 (enExample)
JP (1) JP6837015B2 (enExample)
KR (1) KR102713511B1 (enExample)
CN (2) CN108076643B (enExample)
AU (1) AU2016287200B2 (enExample)
CA (1) CA2989977A1 (enExample)
MX (1) MX383921B (enExample)
RU (1) RU2758109C2 (enExample)
WO (1) WO2017001440A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102713511B1 (ko) 2015-06-29 2024-10-04 훼링 비.브이. 세균성 질증의 치료를 위한 락토바실러스 람노서스 박테리아
EP3427745A1 (en) 2017-07-12 2019-01-16 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO New probiotic composition for prevention of bacterial vaginosis
CN108004188B (zh) * 2018-01-11 2020-02-14 广东龙创基药业有限公司 一种鼠李糖乳杆菌及其用于制备阴道抑菌药物的应用
RU2703708C1 (ru) * 2018-10-08 2019-10-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования степени риска нарушения микробиоты влагалища
MX2022014160A (es) * 2020-06-01 2022-11-30 Ferring Bv Composiciones de microbiota vaginal.
PL4165220T3 (pl) * 2020-06-11 2024-11-18 ADM Denmark A/S Kompozycja probiotyczna i jej zastosowanie przeciwko infekcjom candida
PT3939602T (pt) * 2020-07-14 2024-07-10 Probisearch S L U Estirpe de lactobacillus salivarus ps11610 e seu uso na prevenção e tratamento de disbiose do trato urogenital
KR102546934B1 (ko) 2021-04-02 2023-06-23 대한민국 락토바실러스 람노서스 kcc-51 균주 및 이를 포함하는 조성물
CN113287753A (zh) * 2021-05-24 2021-08-24 国珍健康科技（北京）有限公司 一种用于改善女性阴道炎症的益生菌组合物
CN115252655B (zh) * 2022-07-14 2023-06-16 金华银河生物科技有限公司 用于改善阴道炎症的益生菌后生元制品及制备方法和应用
CN115569154B (zh) * 2022-09-21 2024-06-11 微康益生菌(苏州)股份有限公司 防治念珠菌阴道炎的鼠李糖乳杆菌LRa05及其应用
CN118077903B (zh) * 2024-03-27 2024-09-17 瀚天生物(北京)科技有限公司 一种用于女性改善阴道紧致和水润环境的口服益生菌复合制剂及其制备方法与应用
WO2025210272A1 (en) * 2024-04-05 2025-10-09 Ferring B.V. Composition comprising lactobacillus species for vaginal therapies

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012035028A1 (en) * 2010-09-14 2012-03-22 Hso Health Care Gmbh Compositions for the vaginal and oral administration of lactobacillus and uses thereof
CN102835657A (zh) * 2011-06-20 2012-12-26 丰华生物科技股份有限公司 用以抑制发炎反应及抗阴道炎的含乳酸菌食品组合物及医药组合物
CN103409334A (zh) * 2013-01-16 2013-11-27 生合生物科技股份有限公司 抑制阴道炎病原菌之乳酸杆菌及其用途
WO2014093486A1 (en) * 2012-12-11 2014-06-19 Juras Suzanah Natural intra-vaginal inserts to control imbalanced ph

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8603338D0 (sv) 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
FR2672300B1 (fr) * 1991-02-01 1994-09-23 Agronomique Inst Nat Rech Xylanase, souches de bacillus productrices de xylanase et leurs utilisations.
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
PT956858E (pt) * 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
CA2354054C (en) * 1998-12-11 2011-04-12 Urex Biotech, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
US20020044926A1 (en) * 1999-12-10 2002-04-18 Gregor Reid Oral administration of lactobacillus for the treatment and prevention of urogenital infection
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
US20040022775A1 (en) * 2002-04-15 2004-02-05 Gregor Reid Methods of treating viral infections in mammals
WO2006071864A1 (en) * 2004-12-23 2006-07-06 Rutgers, The State University Of New Jersey Compositions and methods for the prophylaxis and treatment of vaginal infections
WO2006088923A2 (en) * 2005-02-15 2006-08-24 Gorbach Sherwood L A food containing a probiotic and an isolated beta-glucan and methods of use thereof
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
EP2216036A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
AR090631A1 (es) * 2012-04-09 2014-11-26 Chr Hansen As Bioproteccion que usa cepas lactobacillus rhamnosus
FR2992861B1 (fr) * 2012-07-09 2014-10-17 Probionov Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
JP6110240B2 (ja) * 2013-04-10 2017-04-05 国立大学法人広島大学 乳酸菌の菌体等、並びにこれらを含有する口腔内疾患の予防材等及び食品
RU2570622C2 (ru) * 2013-10-24 2015-12-10 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" ШТАММ Lactobacillus rhamnosus, ОБЛАДАЮЩИЙ АНТИБАКТЕРИАЛЬНОЙ И АНТИГРИБКОВОЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ ПАТОГЕННОЙ И УСЛОВНО-ПАТОГЕННОЙ ВАГИНАЛЬНОЙ МИКРОФЛОРЫ
KR102713511B1 (ko) 2015-06-29 2024-10-04 훼링 비.브이. 세균성 질증의 치료를 위한 락토바실러스 람노서스 박테리아

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012035028A1 (en) * 2010-09-14 2012-03-22 Hso Health Care Gmbh Compositions for the vaginal and oral administration of lactobacillus and uses thereof
CN102835657A (zh) * 2011-06-20 2012-12-26 丰华生物科技股份有限公司 用以抑制发炎反应及抗阴道炎的含乳酸菌食品组合物及医药组合物
WO2014093486A1 (en) * 2012-12-11 2014-06-19 Juras Suzanah Natural intra-vaginal inserts to control imbalanced ph
CN103409334A (zh) * 2013-01-16 2013-11-27 生合生物科技股份有限公司 抑制阴道炎病原菌之乳酸杆菌及其用途

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomi zed, placedo-controlled trial in 64 healthy women;Gregor Reid等;《FEMS Immunology and Medical Microbiology》;20030301;第35卷(第2期);第131-134页 *
Selection of Lactobacillus Strains for Urogenital Probiotic Applications;Gregor Reid and Andrew W. Bruce;《The journal of infectious diseases》;20010301;第181卷;第s77-s80页 *
鼠李糖乳杆菌GR-1和罗伊氏乳杆菌RC-14防治阴道炎的研究进展;钟燕 等;《国际妇产科学杂志》;20131015;第40卷(第5期);参见摘要、第429-430页 *

Also Published As

Publication number Publication date
WO2017001440A1 (en) 2017-01-05
KR102713511B1 (ko) 2024-10-04
RU2017143465A3 (enExample) 2019-11-20
US20200268815A1 (en) 2020-08-27
RU2758109C2 (ru) 2021-10-26
CN113564075A (zh) 2021-10-29
JP2018520677A (ja) 2018-08-02
MX2017016748A (es) 2018-11-09
CN108076643A (zh) 2018-05-25
US11202813B2 (en) 2021-12-21
AU2016287200A1 (en) 2018-01-18
US10588926B2 (en) 2020-03-17
KR20180021777A (ko) 2018-03-05
CA2989977A1 (en) 2017-01-05
RU2017143465A (ru) 2019-08-01
US20180228850A1 (en) 2018-08-16
JP6837015B2 (ja) 2021-03-03
MX383921B (es) 2025-03-14
AU2016287200B2 (en) 2020-09-17

Similar Documents

Publication Publication Date Title
US11202813B2 (en) Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis
AU2008257455B2 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
CN110122877B (zh) 鼠李糖乳杆菌及其用途
US9649347B2 (en) Protective effects and application of a Lactobacillus rhamnosus on the alleviation of chronic alcoholic liver injury
KR100686558B1 (ko) 체지방 저하 기능성 락토바실러스 플랜타륨와 이를 함유한 식품
US20140363501A1 (en) The protective effects and application of a Lactobacillus rhamnosus on the alleviation of chronic alcoholic liver injury
JP3940929B2 (ja) コレステロールを低下および同化する能力を有する酸および胆汁酸塩耐性のＬａｃｔｏｂａｃｉｌｌｕｓ分離株
WO2012035028A1 (en) Compositions for the vaginal and oral administration of lactobacillus and uses thereof
CN116064313B (zh) 植物乳杆菌ccfm1281在缓解运动性疲劳中的应用
CN117159598B (zh) 植物乳植杆菌Lp18在制备增强免疫的药物或保健食品方面的用途及产品
KR20230154400A (ko) 락토바실러스 플란타럼 hom3201 균주 및 이의 생균 제제, 제조 방법 및 용도
CN116024131A (zh) 一种植物乳杆菌菌株goldgut-lp101及用途
CN116396890A (zh) 用于防治结肠癌的植物乳杆菌zjuids15及其应用
CN113528367B (zh) 一株具有预防腹泻和降解胆固醇功能的凝结芽孢杆菌
CN110141584B (zh) 一种开菲尔乳杆菌m11在抑菌及作为治疗ⅱ型糖尿病药剂的活性成分的应用
CN117327604A (zh) 包含鼠李糖乳杆菌菌株的活菌制剂及其用途
CN103987839B (zh) 能够抑制幽门螺杆菌菌株粘附至上皮细胞的新德式乳杆菌保加利亚亚种菌株
ES2740979T3 (es) Bacteria Lactobacillus rhamnosus para el tratamiento de, por ejemplo, la vaginosis bacteriana
CN110141583B (zh) 一种开菲尔乳杆菌m3在抑菌及作为治疗ⅱ型糖尿病药剂的活性成分的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant